Top hospitals more likely to use stents and clot-inhibiting drugs in angioplasty.
Rollins
G
G
D015906:Angioplasty, Balloon, Coronary / Q000191:economics / Q000379:methods; D000925:Anticoagulants / Q000191:economics / Q000627:therapeutic use; D019985:Benchmarking; D005343:Fibrinolytic Agents / Q000191:economics / Q000627:therapeutic use; D006761:Hospitals; D006801:Humans; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors / Q000191:economics / Q000627:therapeutic use; D015607:Stents / Q000191:economics; D014481:United States
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D019039:Platelet Glycoprotein GPIIb-IIIa Complex